Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study

10 Aug 2026 · 18:06 UTC

Observed price moves

AQST-0.89%15 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next. We pay about $120,000 a month for the newswires behind this feed.